VMP 41786211000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Entecavir 500microgram tablets
BNF code 0503031B0AAAAAA
Virtual Therapeutic Moiety Entecavir
Date identifier became valid 12 May 2023
Previous product identifier 417515001
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Entecavir monohydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 416644000
Strength value numerator 500.000
Strength value numerator unit microgram
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Baraclude 0.5mg tablets (Abacus Medicine Ltd)
Baraclude 0.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
Entecavir 500microgram tablets (A A H Pharmaceuticals Ltd)
Entecavir 500microgram tablets (Accord-UK Ltd)
Entecavir 500microgram tablets (Alliance Healthcare (Distribution) Ltd)
Entecavir 500microgram tablets (Amarox Ltd)
Entecavir 500microgram tablets (Aristo Pharma Ltd)
Entecavir 500microgram tablets (Cipla EU Ltd)
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd)
Entecavir 500microgram tablets (Medihealth (Northern) Ltd)
Entecavir 500microgram tablets (Milpharm Ltd)
Entecavir 500microgram tablets (Sun Pharmaceutical Industries Europe B.V.)
Virtual Medicinal Product Packs
Entecavir 500microgram tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback